Deficiencies in circulating testosterone and dehydroepiandrosterone sulphate, and depression in men with systolic chronic heart failure.
OBJECTIVE
Elderly men with androgen deficiencies are prone to develop late-onset depression. We investigated links between circulating androgens and depression, and their combined impact on outcome in men with chronic heart failure (CHF).


RESULTS
Serum total testosterone (TT) and dehydroepiandrosterone sulphate (DHEAS) were measured using immunoassays in 163 men with stable systolic CHF [age: 60 +/- 10 years, NYHA class (I/II/III/IV): 27/84/46/6] and 316 healthy men. Depression was assessed using Beck Depression Inventory (BDI) and defined as BDI > or =16 points. In men with CHF, reduced TT and DHEAS, advanced NYHA class, elevated N-terminal pro-B type natriuretic peptide (NT-proBNP), reduced glomerular filtration rate, and reduced haemoglobin independently predicted severity of depressive symptoms (all P < 0.05). Depression was present in 20, 37 and 77% of men with no androgen deficiency, either TT or DHEAS deficiency, and both androgen deficiencies, respectively (P < 0.0001). During follow-up (median: 28 months), there were 87 (53%) cardiovascular deaths or unplanned hospitalizations. TT and DHEAS deficiencies (defined as < or = the 10th percentile of serum androgen levels in healthy controls) and BDI > or =16 points independently predicted unfavourable outcome (all P < 0.05).


CONCLUSIONS
TT and DHEAS deficiencies predict severity of depression in men with CHF. Depression and combined androgen deficiencies are independently related to poor outcome in these patients.
Jankowska
Ewa A
EA
Department of Heart Diseases, Faculty of Health Sciences, Wroclaw Medical University Military Hospital, Wroclaw, Poland. Ewa.Jankowska@antro.pan.wroc.pl
Drohomirecka
Anna
A
Ponikowska
Beata
B
Witkowska
Agnieszka
A
Lopuszanska
Monika
M
Szklarska
Alicja
A
Borodulin-Nadzieja
Ludmila
L
Banasiak
Waldemar
W
Poole-Wilson
Philip A
PA
Ponikowski
Piotr
P
D000328:Adult; D015415:Biomarkers / Q000097:blood; D003687:Dehydroepiandrosterone / Q000097:blood / Q000172:deficiency*; D003863:Depression / Q000097:blood* / Q000150:complications; D018450:Disease Progression; D005500:Follow-Up Studies; D054143:Heart Failure, Systolic / Q000097:blood* / Q000150:complications / Q000401:mortality; D006801:Humans; D007118:Immunoassay; D008297:Male; D008875:Middle Aged; D011044:Poland / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D013739:Testosterone / Q000097:blood / Q000172:deficiency*
D015415:Biomarkers; D013739:Testosterone; D003687:Dehydroepiandrosterone